Niko Price’s Reported UFC Vegas 122 Return Revives a High-Variance Betting Profile

Niko Price’s retirement lasted 167 days between bouts—at least if his reported return goes forward.

MMA Mania reported that Price will face Leon Shahbazyan at UFC Vegas 122 on Oct. 10, 2026, framing the booking as a final Octagon appearance after Price tried to retire following his March loss to Michael Chiesa. Our database does not yet have the bout linked, and it contains no opponent profile for Shahbazyan. That distinction matters: the announcement restores Price to the betting conversation, but it does not provide enough evidence to handicap both sides.

What Price brings is already clear. He has produced or conceded abrupt endings throughout a 21-bout UFC archive, and his latest run has pushed that volatility toward the wrong side of the ledger. Any eventual betting case must begin with the mechanics behind those outcomes—not the appeal of a “last dance.”

The comeback follows three consecutive stoppage losses

Price enters the reported matchup on a four-fight losing streak. The sequence began with a unanimous-decision loss to Themba Gorimbo, followed by a second-round submission against Jacobe Smith, a first-round knockout against Nikolay Veretennikov and a first-round submission against Chiesa.

That is the central change for bettors. Price was once dangerous enough to create several different finishing routes, but his recent fights have ended before he could sustain offense. Three straight opponents have stopped him, and two did it in the opening round. Across his full UFC archive, Price has been finished nine times in 11 losses.

Those results directly touch fight-goes-the-distance, total-rounds, method-of-victory and round-betting markets. The mechanism is not simply that Price is losing. His defensive layers have repeatedly failed early enough to shorten the fight: one opponent broke through with strikes, while two others found submissions. That variation makes a narrow opponent-specific method difficult to isolate, but it strengthens the case for treating duration as the first market to investigate once Shahbazyan’s data becomes available.